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All participants are member of the Expertise Centre on rare disease: prenatal diagnosis of neuromuscular disorders especially FADS.

What\'s known: {#pd5411-sec-1121}
==============

Systematic motor assessment for differentiation, quality, and quantity of the movements has been performed in a high‐risk population for FADS.[1](#pd5411-bib-0001){ref-type="ref"} Families with recurrent FADS were examined every 2 weeks from 12 to 24 weeks of gestation. The fetuses suspected of FADS were compared with a normal population and abnormalities in motor assessment were used to detect recurrent disease. This analysis revealed abnormal quality in all fetuses with deterioration in a 2 week period, reduced differentiation in the majority and only half showed abnormal quantity.

What\'s new: {#pd5411-sec-2122}
============

This study evaluates whether motor assessment, in addition to advanced ultrasound examination in case of multiple contractures, supports the timely diagnosis of FADS. All consecutive fetuses with more than two contractures on the 20‐week structural anomaly scan were included; findings at AUE, including motor assessment, were analysed and related to outcome. It is the first study that uses motor assessment to make a distinction in the diagnosis between BPEV, AMC, and FADS.

1. INTRODUCTION {#pd5411-sec-0005}
===============

Prenatal detection of the phenotype fetal akinesia deformation sequence (FADS) through ultrasound examination has been reported as early as the first trimester of pregnancy, but also during the third trimester with varied expressions, making diagnosis challenging.[1](#pd5411-bib-0001){ref-type="ref"}, [2](#pd5411-bib-0002){ref-type="ref"}, [3](#pd5411-bib-0003){ref-type="ref"} Arthrogryposis multiplex congenita (multiple contractures in various regions, AMC) including FADS was missed in 73.8% during prenatal ultrasound examination in 107 cases with neonatal confirmed arthrogryosis.[4](#pd5411-bib-0004){ref-type="ref"}

Sonographically prenatal diagnosis of FADS is based on multiple contractures, reduced motility, flattening of facial profile and---with increasing gestational age---growth restriction, reduced cardiothoracic ratio, and polyhydramnios.[1](#pd5411-bib-0001){ref-type="ref"}, [4](#pd5411-bib-0004){ref-type="ref"}, [5](#pd5411-bib-0005){ref-type="ref"}, [6](#pd5411-bib-0006){ref-type="ref"} Although FADS is considered to be an expression of various autosomal recessive disorders, DNA‐diagnostic possibilities during pregnancy are still limited.[4](#pd5411-bib-0004){ref-type="ref"} Single clubfeet to AMC can be seen at the onset of FADS. Clubfeet, multiple contractures, and FADS have a prevalence of 1 to 3:1000,[7](#pd5411-bib-0007){ref-type="ref"} 1:3000 to 5000, and 1:13 000 pregnancies, respectively.[5](#pd5411-bib-0005){ref-type="ref"} The prognosis of FADS is dependent on its cause. Approximately 30% are stillborn, the majority of live‐born infants die of pulmonary hypoplasia.[8](#pd5411-bib-0008){ref-type="ref"}

Abnormal motility has been reported when FADS was suspected.[1](#pd5411-bib-0001){ref-type="ref"}, [9](#pd5411-bib-0009){ref-type="ref"}, [10](#pd5411-bib-0010){ref-type="ref"}, [11](#pd5411-bib-0011){ref-type="ref"}, [12](#pd5411-bib-0012){ref-type="ref"}, [13](#pd5411-bib-0013){ref-type="ref"} Systematic motor assessment for differentiation into specific movement patterns, quality of general movements, isolated arm/leg movements, and quantity of general movements have been performed in a high‐risk population for FADS, irrespective of gestational age in our multidisciplinary expert centre: prenatal centre for diagnosing neuromuscular disorders, in particular FADS.[1](#pd5411-bib-0001){ref-type="ref"} This analysis revealed abnormal quality in all fetuses with deterioration in a 2‐week period, reduced differentiation in the majority, and only half showed abnormal quantity.

The present study evaluates whether motor assessment, in addition to advanced ultrasound examination (AUE) in case of multiple contractures, supports the timely prenatal diagnosis of FADS before 24 weeks of gestation. All consecutive fetuses with multiple contractures will be presented together with their outcome and follow‐up examinations since the introduction of the 20‐week standard anomaly (2007) from one tertiary centre in the Netherlands. We expected that additional single and/or repeated sonographic motor assessment would support the distinction between the phenotypes AMC and FADS before 24 weeks of gestation, the utmost gestational age at which termination of pregnancy (TOP) is permitted in the Netherlands.

2. METHODS {#pd5411-sec-0006}
==========

2.1. Population {#pd5411-sec-0007}
---------------

Women who underwent an AUE for multiple contractures in the tertiary hospital VU University Medical Centre during the period from 2007 to 2016 were extracted from the digitalized ultrasound database, ASTRAIA Software GmbH, Copyright 2000‐2016©, version 1.24.8 P1 54095.3245. The database was searched for the following terms: contracture(s), FADS, Pena‐Shokeir (prior nomenclature of FADS), limb deformity, AMC, and hypokinesia. The inclusion criteria were; more than one contracture at the 20‐week standard anomaly scan and/or AUE and availability of a motor assessment. Data were stored in an anonymized digital database containing the results of the AUE, the postural and motor assessment together with the outcome measures, and if known, the underlying disease. Approval of the local research ethics committee was obtained from the Amsterdam UMC, location VUmc. Ethical approval was waived by the ethics committee of the Amsterdam UMC, location VUmc since it is a retrospective study without patient identifiers.

2.2. Definitions of FADS, AMC, and bilateral clubfeet {#pd5411-sec-0008}
-----------------------------------------------------

At the first and second structural assessment, bilateral pes equinovares (BPEV) was defined as bilateral clubfeet without contractures in other regions or structural abnormalities related to FADS, eg, polyhydramnios, IUGR, flattened face profile, and/or increased cardiothoracic ratio. AMC was defined as multiple contractures in more than one region, eg, arms and legs, without other structural abnormalities related to FADS. FADS was defined as contractures in combination with other structural abnormalities related to FADS.

At the first and second motor assessment, the information of abnormal motility in addition to the structural assessment was used to confirm the diagnosis of FADS based on the structural assessment or change the diagnosis of AMC/BPEV into FADS. Suspect motility at the motor assessment did not change the diagnosis based on the structural assessment. For classification of normal, suspect, and abnormal motility, see Table [1](#pd5411-tbl-0001){ref-type="table"}.

###### 

The motor assessment adapted from Donker et al.[1](#pd5411-bib-0001){ref-type="ref"}

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                           Description                                                                                                                                                                                                                                                                                                    Normal                                                                                                                                     Abnormal                                                                                       FADS suspected
  -------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------ ---------------------------------------------------------------------------------------------- ----------------
  Differentiation into specific movement patterns (SMPs)   SMPs are:‐ general movement (GM)‐ isolated arm movement (IAM)‐ isolated leg movement (ILM),‐ breathing movement‐ hand--face contact, startle ‐ hiccup, jaw opening, sucking and swallowing, stratching, isolated retroflexion head, isolated anteflexion head, isolated rotation head, yawning, twitch spine   ≥8 SMPs in a 15‐minute observation                                                                                                         \<8 SMPs in 15‐minute observation\                                                             +/−
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     (FADS fetuses had 7+/−2 SMPs)                                                                  

  Quality                                                  Quality of GM, IAM, and ILM\                                                                                                                                                                                                                                                                                   Variation in all aspects.\                                                                                                                 Suspect:No variation in one or two aspects. GM abnormal:\                                      \+
                                                           The six aspects:1. Apmlitude 2. Speed 3. Participanting body parts 4. Complexity in the direction\                                                                                                                                                                                                             If the IAMs/ILMs are normal, except for the affected joints, the quality is also considered normal.                                        No variation in three or four aspects for GM. ILM/IAM abnormal:\                               
                                                           5. Fluent movements\                                                                                                                                                                                                                                                                                                                                                                                                                                      No variation in two aspects for ILM/IAM.                                                       
                                                           6. Waxing and waning                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Quantity                                                 Quantity of the movements                                                                                                                                                                                                                                                                                      GMs above the 10th percentile from a normal population examined throughout gestation 8 to 40 weeks[14](#pd5411-bib-0014){ref-type="ref"}   GMs below the 10th percentile of the normal population[14](#pd5411-bib-0014){ref-type="ref"}   +/−
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

+: yes, FADS suspected +/−: only for the severity of FADS.

2.3. Motor assessment {#pd5411-sec-0009}
---------------------

The systematic motor assessment is performed during a 15‐minute ultrasound examination. The observation time was doubled in case of absence of motility during 13 minutes or more, since this is the maximal pause between consecutive movements in a normal population at this gestational age.[13](#pd5411-bib-0013){ref-type="ref"} During the examination, the investigator holds the probe still, visualizing the head/jaw, trunk, and part of the arm and leg of the fetus. The evaluation consists of three aspects: (1) observation of the differentiation into specific movement patterns, (2) quality of general movements, isolated arm and leg movements, and (3) quantity of movements. The evaluation is adapted from Donker et al[1](#pd5411-bib-0001){ref-type="ref"} (Table [1](#pd5411-tbl-0001){ref-type="table"}).

The phenotype FADS was diagnosed if the quality of the motility was abnormal, with or without reduced differentiation into specific movement patterns or quantity. From the 10‐year cohort of Donker et al,[1](#pd5411-bib-0001){ref-type="ref"} we learned that in FADS cases, the quality was abnormal in all, however, not the quantity (only in half) and differentiation. Still, in case of severe deteriorated FADS, examination of the differentiation and quantity supported to diagnose FADS. In two cases, the quality could not be evaluated since general movements were absent.

The motor assessment was recorded digitally to facilitate offline examination. After 2 weeks, the motor assessment was repeated until 24 weeks of gestation to detect changes over time (deterioration, amelioration, and stability). The recordings and assessments were performed by dedicated advanced ultrasound MD\'s; van der Knoop, Adriaanse, Burger, or Schreurs, and all recordings were assessed and consented to by de Vries. We have reported good inter‐observer agreement in pregnancies and fetuses affected with FADS concerning the three motor aspects, differentiation into specific movement patterns Cohen\'s kappa 0.95, movement quality Cohen\'s kappa 0.83, and on quantity of general movements Pearson correlation *r* = 0.88.[1](#pd5411-bib-0001){ref-type="ref"}

2.4. Postural and other ultrasound findings related to FADS {#pd5411-sec-0010}
-----------------------------------------------------------

The following findings were stored from all fetuses; contractures in the upper and/or lower limbs, facial anomalies, increased cardiothoracic circumference ratio (CT‐ratio), and presence of polyhydramnios**.** The face was examined for micro‐ and/or retrognathia, flattened nose, and reduced prominence of the lips.

2.5. Outcome measures {#pd5411-sec-0011}
---------------------

The structural and motor assessment of all cases were discussed by a multidisciplinary team consisting of the prenatal staff of obstetricians, neonatologist, sonographers, clinical geneticist, and child neurologist. The parents were offered consultations with the clinical geneticist, child neurologist, or orthopaedic surgeon if applicable, and were counselled by the obstetrician with the obtained knowledge on the prognosis, and decided for continuation or TOP and location of delivery. Outcome parameters were: live born infant, results of paediatric, orthopaedic, and if available, neurologic evaluation. In case of a TOP or perinatal death, post‐mortem examination was offered. The results of the consultation with the clinical geneticist together with the chromosome and DNA‐investigations were, if available, recorded. The outcome of the pregnancy and outcome of the child was derived from the medical chart of the women giving birth in our hospital. In case of delivery elsewhere, information about the pregnancy outcome was sent to our clinic by the referring hospital and recorded in Astraia.

2.6. Confirmation of diagnosis {#pd5411-sec-0012}
------------------------------

The prenatal diagnosis was examined postnatally by the different disciplines. The living neonates were seen by the paediatrician and orthopaedic surgeon for physical examination of the contractures. In case of TOP or perinatal death, the diagnosis was investigated by the pathologist and clinical geneticist when permitted by the parents. The evaluation of the contractures of the joints in combination with the dysmorphologic features together with the histologic and genetic evaluations led to the diagnosis FADS, AMC, or BPEV.

2.7. Descriptive statistics {#pd5411-sec-0013}
---------------------------

To examine whether motor assessment had additional value in the distinction between BPEV, AMC, and FADS, the diagnoses are presented in four steps. They were based on the: (1) the first structural AUE, (2) additional first motor assessment, (3) 2 weeks later second structural AUE, and (4) the second motor assessment, also 2 weeks later. Confirmation of the prenatal diagnosis was based on the various outcome parameters described above.

3. RESULTS {#pd5411-sec-0014}
==========

3.1. Study population {#pd5411-sec-0015}
---------------------

A total of 260 ultrasound recordings matched the search containing 140 fetuses from 128 women. Of the 140 cases, 74 were excluded because they did not meet the criteria. The prenatal diagnosis of these 74 fetuses, together with their outcome, are presented in Table [2](#pd5411-tbl-0002){ref-type="table"}. In 16 of 74 cases, no motor assessment had been performed, no other anomalies were suspected, and one developed FADS, a stillborn boy was delivered at 30 weeks. In the same time period, another fetus suspected of FADS presented itself at 35 weeks. The fetus, however, did not fulfil the inclusion criteria of the present study, since no contractures were observed at the 20 weeks structural anomaly scan. The case was referred to our hospital at 35 weeks for polyhydramnios, limited stomach filling, and reduced motility. The mother had experienced reduced fetal movements from 24 weeks onwards. Motor assessment at 35 weeks was suspect for FADS. At 35 weeks and 3 days a stillborn boy was born. FADS was confirmed at post‐mortem examination.

###### 

Prenatal diagnoses and outcome of the excluded fetuses with AUE before 24 weeks for contractures

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reason of Exclusion               Suspected Diagnosis Prenatally                                            Number   Confirmation   Outcome
  --------------------------------- ------------------------------------------------------------------------- -------- -------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------
  Single contractures               Single contractures                                                       27       27             27 walking

  No motor assessment               Bilateral pes equinovares                                                 14       13             13 walking

                                                                                                                       1 FADS         30 weeks stillborn

  Motor assessment after 24 weeks   Arthrogryposis multiplex congenita\                                       2\       2\             one congenital myotonic dystrophia with mental retardation and delay in motor development, able to walk (with buggy) one intrauterine fetal death two walking
                                    Bilateral pes equinovares                                                 2        2              

  Other suspected diagnosis         Trisomy 18                                                                11       11             Termination of pregnancy (TOP)

                                    Skeletal dysplasia                                                        5        5              TOP

                                    Omphalocele‐exstrophy imperforate anus‐spinal defects                     3        3              TOP

                                    Trisomy 13                                                                2        2              TOP

                                    Spina bifida, ventriculomegaly and bilateral pes equinovares              1        1              TOP

                                    Spina bifida with contractures in hands and pes equinovares bilaterally   1        1              TOP

                                    Hydrancephaly                                                             1        1              TOP

                                    Exencephaly                                                               1        1              TOP

                                    Potter sequence                                                           1        1              TOP

                                    Abdominal cyst with contractures of the legs                              1        1              TOP

                                    Mucopolysaccharidosis type 7                                              1        1              TOP

                                    Unbalanced translocation 9 and 12                                         1        1              TOP
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

The final study population consisted of 66 fetuses from 65 women (median age 32.2 years; range 21.1‐43.8 years). Consanguinity was present in four couples (three BPEV and one FADS), absent in 50, and unknown in 11. The mean gestational age at the first assessment was 20 weeks, the mean gestational age at the second assessment was 22 weeks and 1 day.

3.2. Advanced ultrasound examination and motor assessment {#pd5411-sec-0016}
---------------------------------------------------------

The distribution of the phenotypes BPEV, FADS, and AMC are presented per examination, together with the changes over time (see Figure [1](#pd5411-fig-0001){ref-type="fig"}). First step, based on the structural AUE, with observation of the contractures (44 BPEV, one BPEV together with hip or knee, 15 in upper and lower limbs, four in wrist and elbows/shoulders, two in wrists), flattening of the facial profile (n = 9), polyhydramnios (n = 2), fetal hydrops (n = 3), and increased CT ratio (n = 2). FADS was suspected in 13 of 66 cases, AMC in 12 of 66, BPEV in 40 of 66, and Holt‐Oram Syndrome in one of 66. The latter was confirmed genetically and is not included in Figure [1](#pd5411-fig-0001){ref-type="fig"}.

![Suspected diagnosis based on the advanced ultrasound examination and changes in diagnosis based on the motor assessments, with the decision on termination or continuation of the pregnancy. AMC, arthrogryposis multiplex congenita; FADS, fetal akinesia deformation sequence; BPEV, bilateral pes equinovares; TOP, termination of pregnancy; IUFD, intrauterine fetal death](PD-39-219-g001){#pd5411-fig-0001}

The second structural AUE twice demonstrated progression in contractures, one from contractures in wrist, elbow/shoulder and one from BPEV and knee/hip to contractures in upper and lower limbs. The AUE of the fetus are provided for in Table [A1](#pd5411-tbl-0005){ref-type="table"}.

3.3. Motor assessment {#pd5411-sec-0017}
---------------------

At the first motor assessment, nine of 66 showed reduced differentiation, 18 of 66 reduced quality, and nine of 66 reduced quantity. The second motor assessment showed reduced differentiation in seven of 43, reduced quality in eight of 43, and reduced quantity in three of 43. Individual motor assessments are presented in [Appendix 1](#pd5411-app-0001){ref-type="app"}.

In three of 40, BPEV was changed to FADS after the first motor assessment because of abnormal quality in all. FADS was changed to AMC in five of 13 because of normal quality, differentiation, and quantity in all. AMC was changed to FADS in 10 of 13 because of abnormal quality in all, abnormalities in all aspects in one of 10, and abnormal quality and differentiation in one of 10; besides this, reduced quantity was seen in two of 10.

At the second motor assessment, the quality was progressively abnormal in eight cases. Reduction of amplitude, speed, and participation was seen in all, reduction in waxing and waning of the general movement was seen in five of eight fetuses, and reduced fluency in one of eight. However, in one of these FADS cases, the hypokinetic movements alternated with hyperkinetic movements with increased twitches and abrupt general movements. In four cases, quality and differentiation could not be assessed because the quantity of the movements was too low.

At the second motor assessment, BPEV was changed to FADS in one of 30 because of abnormal quality (see Figure [1](#pd5411-fig-0001){ref-type="fig"}). FADS was changed to AMC in two of 10 because of reduced variability of the quality but not in the pattern known for FADS, but the majority of general movements, isolated arm and leg movements were performed without fluency.

In two cases three motor assessments could be performed before 24 weeks gestational age, the results of the third examination were in line with the second motor assessment, and did not change the diagnoses.

Late referral gave no time before 24 weeks for repeated motor assessment after 2 weeks in 10 cases. Because of a reassuring first assessment and no other signs of FADS, the pregnancies were continued. None in this group developed FADS, and BPEV was confirmed in all after birth.

One TOP was performed in a fetus with BPEV after the first structural and motor assessment; motor assessment demonstrated normal motility. The diagnosis, BPEV was confirmed by autopsy after TOP.

The pregnancy outcome was available for all fetuses and the prenatal diagnosis of FADS, AMC, and BPEV or other contractures at the latest examination were confirmed by postnatal examination in all fetuses. In four cases, an underlying diagnosis was found in addition to BPEV (spinal muscular atrophy, Down\'s syndrome, Zellweger syndrome, and lissencephaly). A detailed description with the phenotype suspected prenatally, decision concerning the pregnancy, diagnosis postnatally, the investigation, and consultations after birth are depicted for all the cases in Table [3](#pd5411-tbl-0003){ref-type="table"}. In six of 18 FADS, genetic examination showed an underlying cause; MUSK mutation, SCN4A mutation (n = 2), RyR1 mutation (n = 2), and diastrophic dysplasia. In three of seven fetuses with AMC, an underlying genetic cause was found; nemaline myopathy, a TGFBR1 gene mutation, and a PIEZO2‐gene mutation. Intra uterine fetal death (IUFD) occurred in one fetus with FADS, one with lissencephaly and BPEV, and one with trisomy 21 and BPEV. The follow‐up of the living children is described in Table [4](#pd5411-tbl-0004){ref-type="table"}.

###### 

Outcome of the living infants with bilateral pes equinovares (BPEV) and arthrogryposis multiplex congenita (AMC)

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Living        Confirmation After Birth   Orthopaedic Correction             Walking                 Other diagnoses
  ------------- -------------------------- ---------------------------------- ----------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  BPEV n = 44   43 BPEV\                   41\                                41\                     1 spinal muscular atrophy type 1, died 3 months after birth\
                one single PEV             1                                  1                       1 Zellweger syndrome, not walking at 3 years, dependent on care for all daily life activities, treated by rehabilitation team, paediatrician and child neurologist, disease progresses\
                                                                                                      1 down syndrome\
                                                                                                      1 lissencephaly, intrauterine fetal death\
                                                                                                      None

  AMC n = 5     All                        1\. No\                            With braces\            None\
                                           2. Yes\                            Yes, braces for arms\   None\
                                           3. No\                             With braces\            Nemaline myopathy. Trachea canule required, recurrent lung infections, delayed motor development at 6 years, special school.\
                                           4. No\                             Yes\                    De novo mutation in TGFBR1, possible coherent with Shprintzen‐Goldberg syndrome, walks and cycles, attends regular school, independent for daily life activities.\
                                           5. In the future knee operations   Unknown yet             PIEZO2‐gene mutations, tube feeding, delayed growth,
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Outcome after birth based on orthopaedic, post‐mortem and genetic examination and evaluation

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Number   Diagnosis After Birth                              Orthopaedic Surgeon                                                Pathologist (Findings in Addition to Ultrasound)                                                                                                                                                                                                                                                                                                              Clinical Geneticist                                                              Birthweight in Gram   Apgar After 5 min
  -------- -------------------------------------------------- ------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------- --------------------- -------------------
  1        BPEV                                               Ponseti method                                                     ‐                                                                                                                                                                                                                                                                                                                                                             ‐                                                                                **2255**              **9**

  2        BPEV                                               Ponseti method                                                     ‐                                                                                                                                                                                                                                                                                                                                                             ‐                                                                                **2935**              **10**

  3        BPEV                                               Ponseti method                                                     ‐                                                                                                                                                                                                                                                                                                                                                             ‐                                                                                **3295**              **10**

  4        BPEV                                               Ponseti method                                                     ‐                                                                                                                                                                                                                                                                                                                                                             ‐                                                                                **2818**              **10**

  5        BPEV                                               Ponseti method                                                     ‐                                                                                                                                                                                                                                                                                                                                                             ‐                                                                                **3375**              **10**

  6        BPEV                                               Ponseti method with surgery                                        ‐                                                                                                                                                                                                                                                                                                                                                             ‐                                                                                **3690**              **10**

  7        BPEV                                               Ponseti method                                                     ‐                                                                                                                                                                                                                                                                                                                                                             ‐                                                                                **2960**              **10**

  8        BPEV                                               Ponseti method with surgery                                        ‐                                                                                                                                                                                                                                                                                                                                                             ‐                                                                                **3490**              **10**

  9        FADS                                               ‐                                                                  Low implant of the ears, short and deep implant of the nose bridge, micro‐, retrognathia, webbing and contractures of all joints, both hands and feet arachnodactyly, syndactyly, palatal schisms, and small thorax;Normal internal organs, lung hypoplasiaX‐ray: No signs of dysplasiaBrain dissection: Normal                                               No gene mutations found                                                          **303**               **0**

  10       FADS                                               ‐                                                                  Contractures elbows, hips and left knee, small pointy chin, and dystrophic musclesNormal internal organsBrain: Possibly micro gyri                                                                                                                                                                                                                            No gene mutations found                                                          **642**               **0**

  11       FADS                                               ‐                                                                  Relatively small hart                                                                                                                                                                                                                                                                                                                                         No gene mutations found                                                          **605**               **0**

  12       FADS                                               ‐                                                                  No post‐mortem examinationX‐ray: No signs of dysplasia                                                                                                                                                                                                                                                                                                        No gene mutations found                                                          **248**               **0**

  13       AMC                                                ‐                                                                  Horseshoe kidney, palatal schisms                                                                                                                                                                                                                                                                                                                             No gene mutations found                                                          **570**               **0**

  14       FADS, underlying diagnosis diastrophic dysplasia   ‐                                                                  Short limbs, elbows dislocated, hitchhiker‐thumbs, ulnar deviation fingers, scoliosis;Normal internal organsX‐ray: Short limbs                                                                                                                                                                                                                                Diastrophic dysplasia,\                                                          **655**               **0**
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Compound heterozygous mutation in SLC26A2‐gene: c.931 T \> C and c.1957 T \> A                         

  15       FADS                                               ‐                                                                  Retrognathia, unibrow, small pelvis.Normal internal organsmuscle biopsy: Increased centrally localised nuclei, possibly tubular myopathy Brain dissection: Normal                                                                                                                                                                                             No gene mutations found                                                          **404**               **0**

  16       FADS                                               ‐                                                                  Low implant of the ears and rotated backwards, nose bridge broadened;two lobes in right lung, with rudimentary middle lobe, oval shaped kidney with hilum dorsally rotated, ectopic adrenal gland in thymus, haemorrhage in both hemispheresX‐ray: No signs of dysplasiaBrain dissection: NormalMuscle biopsy: myopathic pattern with reduced type 1 fibres   No gene mutations found                                                          **860**               **0**

  17       FADS                                               ‐                                                                  Low implant of the ears, hypertelorism, contractures in elbow on left sided with webbing, knees;Unicornuate uterus, right lung incomplete septationX‐ray: No signs of dysplasiabrain dissection: Normal                                                                                                                                                       Homozygous missense variant in MUSK gene, of unknown significance                **275**               **0**

  18       FADS                                               ‐                                                                  Micro‐, retrognathia, low implant ears, flat nose, webbing, growth restriction                                                                                                                                                                                                                                                                                Heterozygous mutation in NEB‐gene, probably non‐pathogenic                       **105**               **0**

  19       FADS                                               ‐                                                                  Hypertelorism, retrognathia, short eyelids, high nose bridge, broad nose tip, thin upper lip, low implant of the ears and rotated backwards, atrophic muscles; Normal internal organsX‐ ray: Mirror polydactyly right foot, tibia aplasia Brain dissection: Normal                                                                                            No gene mutations found                                                          **495**               **0**

  20       FADS                                               ‐                                                                  Normal internal organsX‐ray: No signs of dysplasiaBrain dissection: Normal                                                                                                                                                                                                                                                                                    No gene mutations found                                                          **150**               **0**

  21       AMC                                                Ponseti method, wrist extension bars, eventually also elbow bars   ‐                                                                                                                                                                                                                                                                                                                                                             No gene mutations found                                                          **2840**              **1**

  22       AMC                                                Ponseti method with surgery, physiotherapy                         ‐                                                                                                                                                                                                                                                                                                                                                             PIEZO2‐gene mutation                                                             **2505**              **10**

  23       FADS                                               ‐                                                                  Contractures lower limbs, including webbing; Lung hypoplasia;Normal internal organs and nervous system                                                                                                                                                                                                                                                        Homozygous pathogenic mutation in RyR1 gene                                      **3000**              **0**

  24       FADS                                               ‐                                                                  ‐                                                                                                                                                                                                                                                                                                                                                             Homozygous pathogenic mutation in RyR1 gene                                      **11**                **0**

  25       FADS                                               ‐                                                                  Broad fingertips, anteversion nostrils, micrognathia, long philtrum, low implant ears, broad neck, contractures ankles, fingers, hypotrophic musclesGrowth restrictionX‐ray: No signs of dysplasiaMuscle biopsy: myopathy suspected with type 2 atrophia                                                                                                      No gene mutations found                                                          **‐**                 **0**

  26       AMC                                                ‐                                                                  ‐                                                                                                                                                                                                                                                                                                                                                             Phenotypically fitting Amyoplasia                                                **85**                **0**

  27       AMC                                                Physiotherapy                                                      ‐                                                                                                                                                                                                                                                                                                                                                             No gene mutations found                                                          **78**                **0**

  28       BPEV                                               Ponseti method                                                     ‐                                                                                                                                                                                                                                                                                                                                                             ‐                                                                                **489**               **0**

  29       BPEV                                               Ponseti method                                                                                                                                                                                                                                                                                                                                                                                                                   ‐                                                                                **2693**              **10**

  30       BPEV                                               Ponseti method                                                     ‐                                                                                                                                                                                                                                                                                                                                                             ‐                                                                                **3375**              **10**

  31       BPEV                                               Ponseti method                                                     ‐                                                                                                                                                                                                                                                                                                                                                             ‐                                                                                **3830**              **10**

  32       BPEV                                               Ponseti method with surgery                                        ‐                                                                                                                                                                                                                                                                                                                                                             ‐                                                                                **3740**              **10**

  33       BPEV                                               Ponseti method                                                     ‐                                                                                                                                                                                                                                                                                                                                                             ‐                                                                                **3595**              **1**

  34       BPEV                                               Ponseti method                                                     ‐                                                                                                                                                                                                                                                                                                                                                             ‐                                                                                **2690**              **9**

  35       BPEV                                               Ponseti method                                                     ‐                                                                                                                                                                                                                                                                                                                                                             ‐                                                                                **940**               **10**

  36       BPEV                                               No treatment needed                                                ‐                                                                                                                                                                                                                                                                                                                                                             ‐                                                                                **3861**              **10**

  37       BPEV                                               Ponseti method                                                     ‐                                                                                                                                                                                                                                                                                                                                                             ‐                                                                                **3340**              **10**

  38       BPEV                                               Ponseti method                                                     ‐                                                                                                                                                                                                                                                                                                                                                             ‐                                                                                **3202**              **10**

  39       BPEV                                               Ponseti method with surgery                                        ‐                                                                                                                                                                                                                                                                                                                                                             ‐                                                                                **2556**              **10**

  40       BPEV                                               Ponseti method                                                     ‐                                                                                                                                                                                                                                                                                                                                                             ‐                                                                                **3290**              **10**

  41       BPEV                                               Ponseti method                                                                                                                                                                                                                                                                                                                                                                                                                   ‐                                                                                **2930**              **9**

  42       BPEV                                               Ponseti method                                                     ‐                                                                                                                                                                                                                                                                                                                                                             ‐                                                                                **3333**              **10**

  43       BPEV                                               Ponseti method with surgery                                        ‐                                                                                                                                                                                                                                                                                                                                                             ‐                                                                                **3045**              **10**

  44       Down syndrome, BPEV                                ‐                                                                  ‐                                                                                                                                                                                                                                                                                                                                                             Trisomy 21                                                                       **2430**              **10**

  45       BPEV                                               Ponseti method                                                     ‐                                                                                                                                                                                                                                                                                                                                                             ‐                                                                                **4169**              **10**

  46       BPEV                                               Ponseti method                                                     ‐                                                                                                                                                                                                                                                                                                                                                             ‐                                                                                **2260**              **9**

  47       BPEV                                               Ponseti method                                                     ‐                                                                                                                                                                                                                                                                                                                                                             ‐                                                                                **3340**              **10**

  48       BPEV                                               Ponseti method                                                     ‐                                                                                                                                                                                                                                                                                                                                                             ‐                                                                                **3200**              **10**

  49       BPEV                                               Ponseti method with surgery                                        ‐                                                                                                                                                                                                                                                                                                                                                             ‐                                                                                **3320**              **10**

  50       BPEV                                               Ponseti method                                                     ‐                                                                                                                                                                                                                                                                                                                                                             ‐                                                                                **2470**              **9**

  51       Zellweger,BPEV                                     No treatment needed                                                ‐                                                                                                                                                                                                                                                                                                                                                             Compound heterozygote mutation in PEX1 gene                                      **2705**              **7**

  52       BPEV                                               ‐                                                                  ‐                                                                                                                                                                                                                                                                                                                                                             ‐                                                                                **710**               **0**

  53       Spinal muscular atrophy type 1, BPEV               ‐                                                                  ‐                                                                                                                                                                                                                                                                                                                                                             SMA type I,\                                                                     **3424**              **9**
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Homozygous SMN1 gene mutation                                                                          

  54       FADS                                               ‐                                                                  Low implant of the ears, whipped up noseNormal internal organs with malrotation of the intestinesMuscle biopsy: myopathic pattern X‐ray: 11 ribs, hypoplasia first pair, no ossification pubis                                                                                                                                                                Homozygous pathogenic mutations in SCN4A                                         **570**               **0**

  55       Lissencephaly,BPEV                                 ‐                                                                  ‐                                                                                                                                                                                                                                                                                                                                                             ‐                                                                                **2546**              **0**

  56       FADS                                               ‐                                                                  Small thymus, no spleen                                                                                                                                                                                                                                                                                                                                       No gene mutations found                                                          ‐                     **0**

  57       Holt‐Oram syndrome                                 ‐                                                                  ‐                                                                                                                                                                                                                                                                                                                                                             Deletion TBX5 gene                                                               **629**               **1**

  58       AMC                                                Ponseti method with surgery                                        ‐                                                                                                                                                                                                                                                                                                                                                             Nemaline myopathy congenital intermediate form                                   **2110**              **6**

  59       AMC                                                Ponseti method                                                     ‐                                                                                                                                                                                                                                                                                                                                                             Sphrintzen‐Goldberg syndrome, TGFBR1 mutation confirmed                          **3400**              **10**

  60       BPEV                                               Ponseti method with surgery                                        ‐                                                                                                                                                                                                                                                                                                                                                             ‐                                                                                **3160**              **10**

  61       BPEV                                               Ponseti method with surgery                                        ‐                                                                                                                                                                                                                                                                                                                                                             Normal array                                                                     **3415**              **10**

  62       BPEV                                               No treatment needed                                                ‐                                                                                                                                                                                                                                                                                                                                                             ‐                                                                                **4120**              **10**

  63       BPEV                                               Ponseti method with surgery                                        ‐                                                                                                                                                                                                                                                                                                                                                             ‐                                                                                **3106**              **10**

  64       BPEV                                               Ponseti method with surgery                                        ‐                                                                                                                                                                                                                                                                                                                                                             Normal array                                                                     **4036**              **10**

  65       FADS                                               ‐                                                                  ‐                                                                                                                                                                                                                                                                                                                                                             No gene mutations found                                                          **‐**                 **0**

  66       Skeletal dysplasia, presenting as FADS             ‐                                                                  ‐                                                                                                                                                                                                                                                                                                                                                             ‐                                                                                **‐**                 **0**
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: AMC, arthrogryposis multiplex congenital; BPEV, bilateral pes equinovares; FADS, fetal akinesia deformation sequence.

3.4. Follow‐up pregnancies {#pd5411-sec-0018}
--------------------------

From the 18 women diagnosed with FADS (17 cases, less than 24 weeks gestation, and one late referral), nine got pregnant again. Motor assessments were performed biweekly from 12 to 24 weeks gestation because of prior FADS, following the same protocol according to Donker et al.[1](#pd5411-bib-0001){ref-type="ref"} In seven of nine pregnancies, normal motility was seen, healthy children were born. In the two of nine cases, recurrent FADS was suspected, however, no motor assessments were made. In the first case, fetal hydrops was seen at 11 weeks, and TOP was performed at 12 weeks gestation. In the second case, IUFD with signs of fetal hydrops at 13 weeks of gestation was found, TOP was performed. In both cases, the diagnosis of FADS was confirmed by the clinical geneticist and child pathologist by post‐mortem examination.

4. DISCUSSION {#pd5411-sec-0019}
=============

The first 10 years of FADS expertise centre demonstrated the different motor activity of fetuses suspected of FADS in comparison with a normal population and was used to detect recurrent disease. With this knowledge, we expected that systematic motor assessment would be of additional value for the diagnosis of FADS in fetuses showing greater than or equal to two contractures at 20 weeks. During the consecutive 10 years, the descriptive analysis of the AUE over time, with a 100% follow‐up, supported that the extra parameter motor assessment assisted the distinction between the phenotypes of AMC, FADS, and BPEV.

The motor assessment resulted in change of the suspected phenotype based on first structural AUE in 19 of 65, and the second, in three of 43. In the remaining examinations, the motor assessments confirmed the already suspected diagnosis.

Systematic fetal motor assessment, however, is still limitedly applied and not yet regularly performed in AUE. From the three motor aspects studied here, the quality assessment and reduced differentiation into specific movement patterns were most informative about the presence of FADS, whereas quantity was only affected in half. This is in line with Donker et al.[1](#pd5411-bib-0001){ref-type="ref"} The quality of the movement of the fetuses with FADS in our study was abnormal, showing reduced variability: small amplitude, slow movements, movements in one direction only, and reduced participation of the body parts (especially trunk and head). Moreover, the finding that hypokinetic movement patterns can be alternated by hyperkinetic movements in the fetuses suspected for FADS is in agreement with other studies.[1](#pd5411-bib-0001){ref-type="ref"}, [10](#pd5411-bib-0010){ref-type="ref"} Even fetal seizures have been described prior to the emergence of contractures.[10](#pd5411-bib-0010){ref-type="ref"} Decreased fetal movements, independent of its cause, eg, central nervous system abnormalities or restrictive dermopathy, are widely accepted to be the cause of multiple contractures and other sequence anomalies. When severe, it can result in FADS.[15](#pd5411-bib-0015){ref-type="ref"}, [16](#pd5411-bib-0016){ref-type="ref"}, [17](#pd5411-bib-0017){ref-type="ref"}, [18](#pd5411-bib-0018){ref-type="ref"}, [19](#pd5411-bib-0019){ref-type="ref"}, [20](#pd5411-bib-0020){ref-type="ref"}, [21](#pd5411-bib-0021){ref-type="ref"} However, the limited serial motor assessments demonstrated which reduced activity, is a late expression of affected motor activity and possibly not initiating the contractures.[8](#pd5411-bib-0008){ref-type="ref"}, [9](#pd5411-bib-0009){ref-type="ref"}, [10](#pd5411-bib-0010){ref-type="ref"} Though different authors advise evaluation of the fetal motility, until now, the main focus has been on diagnosing the different structural anomalies known to occur with FADS.[2](#pd5411-bib-0002){ref-type="ref"}, [3](#pd5411-bib-0003){ref-type="ref"}, [22](#pd5411-bib-0022){ref-type="ref"}

The varied expressions of the structural anomalies in FADS are illustrated by the following case series. Helmund et al evaluated ultrasound findings, post‐mortem reports, and paediatric charts of 79 cases with FADS.[2](#pd5411-bib-0002){ref-type="ref"} They found that FADS presents with various ultrasound findings, mostly affecting the profile, elbow, knee, ankle joint, wrist, and fingers. Fetal hydrops and nuchal oedema were earlier signs, whereas pulmonary hypoplasia, polyhydramnios, and IUGR were found later in pregnancy.[2](#pd5411-bib-0002){ref-type="ref"} Most of our cases did not show these latter features since the pregnancy was often terminated before 24 weeks of gestation. The second case series on antenatal findings in 21 cases with AMC and FADS examined between 12--30 weeks gestational age suggested that pulmonary hypoplasia is obligatory in FADS and cannot be found in AMC.[3](#pd5411-bib-0003){ref-type="ref"} When pulmonary hypoplasia was found, the pregnancy was terminated. However, this makes counselling before 24 weeks gestational age difficult, since this often emerges thereafter.[2](#pd5411-bib-0002){ref-type="ref"}

The strength of our study is that we prospectively studied all fetuses with more than one contracture as examined at the 20‐week standard anomaly scan, comparing the value of advanced anomaly scan and the additional value of the motor assessment, both repeated after 2 weeks, with a 100% multidisciplinary follow‐up.

A limitation of our study is that the second assessment to detect progression of the motility was not performed in all cases. This was because: (1) the combination of the structural abnormalities, together with severe abnormal motility at first examination, already led to TOP; and (2) late referral allowed no time to timely repeat the ultrasound examination before 24 weeks. Another limitation is that in 16 cases with multiple contractures, 14 with bilateral talipes equinovares and two with AMC, no motor assessment was made. They were missed because of unfamiliarity with the protocol. One of these 16 fetuses developed FADS. Our evaluation emphasises that clinicians need to be aware that the onset of FADS varies, illustrated by the case with FADS at 35 weeks where there were no contractures at 20 weeks, as well as possible underlying disorders in cases of BPEV or AMC. Motor assessment did not reveal the severity of the later developing or ongoing diseases.

We suggest that in cases where multiple contractures are observed on the 20‐week structural anomaly scan, the pregnant woman and partner should be informed about the rare disease resulting in the phenotype FADS and the possibilities of repeated ultrasound examination including the present knowledge on motor assessment before the 24‐week gestational age. Counselling has to be performed with the knowledge of the low prevalence of FADS and higher rate of AMC and BPEV. Moreover, parents have to be made aware that motility is an expression of the central nervous system and neuromuscular system at that very moment. The fetal motility is used as an extra parameter when multiple contractures are seen at the structural anomaly scan. Since the motility is a functional expression of the central nervous system, the motor assessment can be used to counsel the parents about the extensiveness of the findings and can help the parents to make an informed choice to continue or terminate the pregnancy. In this cohort, motor assessment, in addition to the structural ultrasound assessment, resulted in a high‐predictive value nearing 100%, but we are aware that later onset of FADS can be missed before 24 weeks gestation. Hence, late‐onset progressive neuromuscular diseases cannot be excluded. The application of motor assessments should be seen within the scope of AUE.

This manuscript is a second step in creating the awareness of systematic motor assessment supporting the prenatal diagnosis of FADS. The first step assessing in a cohort irrespective of the gestational age (Donker et al. 2009). Second step is the present study accessing a cohort at 20 weeks gestation after the introduction of the 20‐week standard anomaly scan. Our next step is focused on the distinction between normal and abnormal fetal motility by other centres. Presently, we are working on learning strategies recognizing abnormal motility and will apply this on an e‐learning. The hope is that we reach caregivers with interest in this field of neuromuscular disorders. This may help to lower the number of missed FADS. This study tried to demonstrate the additional value of motor assessments. Future studies have to pave the way whether the use of systematic motor assessment can be supported in larger populations and should be implemented in the AUE to detect FADS when contractures are seen. Moreover, finding an underlying genetic cause through next genome sequencing may obtain a more exact diagnosis than prenatal ultrasound examination and autopsy.

5. CONCLUSION {#pd5411-sec-0020}
=============

This is a retrospective study on the additional value of motor assessment to AUE to distinguish between stable AMC or BPEV versus deteriorating AMC into FADS. The results suggest that the expectation that motor assessment is of additional value to distinguish between FADS and AMC/BPEV is plausible.

Multidisciplinary approach during and after pregnancy will enhance counselling, follow‐up treatment, and finding underlying diseases.
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###### 

Individual diagnosis after advanced ultrasonographic examination (AUE) and the motor assessment(s) with decision concerning the pregnancy

       Gesta‐tional   AUE Structural           AUE Motor                                                                                                                                                                   
  ---- -------------- ------------------------ -------------- ---------------------------------------- ---------------------------------------------------------------------------------- ------- ------------------------ --------------
  1    22 + 3         ‐                        BPEV                              \+                                                            ‐                                            \+    FADS                     Continuation
       22 + 6         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
       23 + 3         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
  2    22 + 5         ‐                        BPEV                              ++                                                           +/‐                                           \+    BPEV                     Continuation
       26 + 6         ‐                        BPEV                              ‐                                                             \+                                           \+    BPEV                     Continuation
  3    21 + 5         ‐                        BPEV                              \+                                                            ‐                                            \+    FADS                     Continuation
       23 + 0         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
  4    21 + 3         ‐                        BPEV                              ‐                                                             \+                                           \+    BPEV                     Continuation
       23 + 3         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
       27 + 4         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
  5    24 + 0         F                        FADS                              \+                                                            ‐                                             ‐    FADS                     Continuation
       24 + 1         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
       28 + 0         ‐                        BPEV                              ‐                                                             \+                                           \+    BPEV                     Continuation
  6    19 + 4         ‐                        BPEV                              ‐                                                             \+                                           \+    BPEV                     Continuation
       21 + 4         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
  7    21 + 6         ‐                        BPEV                              ‐                                                             \+                                           \+    BPEV                     Continuation
       23 + 2         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
  8    22 + 2         ‐                        BPEV                              ‐                                                             \+                                           \+    BPEV                     Continuation
  9    16 + 1         CT, fetal hydrops        FADS                              NA                                                            NA                                          ‐ (0)  FADS                     Continuation
       19 + 5         CT, fetal hydrops        FADS                              NA                                                            NA                                          ‐ (0)  FADS                     TOP
  10   23 + 1         ‐                        BPEV                              \+                                                            ‐                                            \+    FADS                     TOP
  11   19 + 2         ‐                        AMC                               \+                                                            ‐                                            \+    FADS                     TOP
  12   19 + 3         Fetal hydrops            FADS                              ‐                                                             ‐                                             ‐    FADS                     TOP
  13   19 + 5         Increased CT‐ratio       FADS                              \+                                                            ‐                                            \+    FADS                     Continuation
       21 + 5         Increased CT‐ratio       FADS                              \+                                                           +/‐                                           \+    AMC                      TOP
  14   23 + 1         ‐                        AMC                               ‐                                                             ‐                                             ‐    FADS                     TOP
  15   21 + 2         F                        FADS                              ‐                                                             ‐                                             ‐    FADS                     TOP
  16   22 + 2         ‐                        AMC                               \+                                                            ‐                                             ‐    FADS                     Continuation
       23 + 3         ‐                        AMC                               ‐                                                            ‐ ‐                                            ‐    FADS                     TOP
  17   17 + 0         ‐                        AMC                               \+                                                            ‐                                            \+    FADS                     Continuation
       19 + 2         ‐                        AMC                               \+                                                           ‐ ‐                                           \+    FADS                     TOP
  18   14 + 3         ‐                        AMC                               \+                                                            ‐                                            \+    FADS                     Continuation
       16 + 3         Increased contractures   FADS                              \+                                                           ‐ ‐                                           \+    FADS                     TOP
  19   17 + 2         Mouth constantly open    FADS                              \+                                                            ‐                                            \+    FADS                     Continuation
       19 + 1         Mouth constantly open    FADS                              ‐                                                             ‐                                            \+    FADS                     Continuation
       21 + 2         Mouth constantly open    FADS                              \+                                                           ‐ ‐                                            ‐    FADS                     TOP
  20   15 + 0         Fetal hydrops            FADS                              NA                                                            NA                                          ‐ (0)  FADS                     Continuation
       17 + 0         Fetal hydrops            FADS                              NA                                                            NA                                          ‐ (0)  FADS                     TOP
  21   22 + 1         ‐                        AMC                               \+                                         +/‐[d](#pd5411-note-0008){ref-type="fn"}                        \+    AMC                      Continuation
       24 + 2         ‐                        AMC                               \+                                                           +/‐                                           \+    AMC                      Continuation
       28 + 1         ‐                        AMC                               \+                                                           +/‐                                           \+    AMC                      Continuation
  22   19 + 3         F                        FADS                              \+                                          ‐[a](#pd5411-note-0005){ref-type="fn"}                         \+    AMC/syndrome             Continuation
       21 + 3         F                        FADS                              \+                                          ‐[b](#pd5411-note-0006){ref-type="fn"}                         \+    AMC/syndrome             Continuation
  23   12 + 2         ‐                        AMC                               NA                                                            NA                                          ‐ (0)  FADS                     TOP
  24   10 + 5         ‐                        AMC                               NA                                                            NA                                          ‐ (0)  FADS                     TOP
  25   13 + 1         ‐                        AMC                               \+                     ‐[a](#pd5411-note-0005){ref-type="fn"} ^,^ [b](#pd5411-note-0006){ref-type="fn"}    \+    FADS                     Continuation
       14 + 6         ‐                        AMC                               ‐                      ‐ ‐[b](#pd5411-note-0006){ref-type="fn"}, [b](#pd5411-note-0006){ref-type="fn"}     \+    FADS                     TOP
  26   22 + 2         ‐                        AMC                               \+                                          ‐[a](#pd5411-note-0005){ref-type="fn"}                         \+    AMC                      TOP
  27   20 + 3         ‐                        AMC                               \+                                                            \+                                           \+    AMC                      Continuation
       22 + 4         F                        FADS                              \+                                                            \+                                           \+    AMC                      Continuation
  28   20 + 2         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
       22 + 0         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
  29   14 + 0         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
       16 + 0         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
  30   18 + 2         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
       20 + 3         ‐                        BPEV                              ‐                                                             \+                                           \+    BPEV                     Continuation
  31   23 + 4         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
  32   22 + 2         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
  33   20 + 3         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
       22 + 3         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
  34   21 + 3         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
  35   23 + 2         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
  36   21 + 5         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
       23 + 5         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
  37   21 + 2         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
  38   21 + 5         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
  39   21 + 3         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
       23 + 1         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
  40   20 + 2         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
       23 + 5         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
  41   22 + 2         P                        FADS                              \+                                                            \+                                           \+    BPEV                     Continuation
  42   22 + 1         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
       28 + 5         ‐                        BPEV                              ‐                                                             \+                                           \+    BPEV                     Continuation
  43   20 + 0         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
       22 + 3         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
  44   23 + 0         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
  45   21 + 1         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
       22 + 6         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
  46   22 + 6         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
  47   20 + 6         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
       22 + 6         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
  48   20 + 0         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
       21 + 6         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
  49   21 + 0         ‐                        BPEV            ‐[c](#pd5411-note-0007){ref-type="fn"}                                          \+                                           \+    BPEV                     Continuation
       22 + 2         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
  50   20 + 6         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
       22 + 6         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
  51   20 + 1         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
       22 + 2         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
  52   22 + 0         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     TOP
  53   20 + 1         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
       22 + 0         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
  54   20 + 5         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
       23 + 4         ‐                        BPEV                              \+                                                            ‐                                            \+    FADS                     TOP
  55   21 + 6         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
       23 + 4         ‐                        BPEV                              ‐                                                             \+                                           \+    BPEV                     Continuation
  56   12 + 5         Prominent head           FADS                             +/‐                                                            \+                                           \+    AMC                      Continuation
       14 + 5         ‐                        FADS                              ‐                                                             ‐                                             ‐    FADS                     IUFD, TOP
  57   20 + 2         Radius aplasia           AMC/syndrome                      \+                                                           +/‐                                           \+    AMC/Holt‐Oram syndrome   TOP
  58   21 + 4         F                        FADS                              \+                                                            \+                                           \+    AMC                      Continuation
       23 + 4         ‐                        FADS                              \+                                                            \+                                           \+    AMC                      Continuation
  59   21 + 2         F                        FADS                              \+                                                            \+                                           \+    AMC                      Continuation
       23 + 2         ‐                        FADS                              \+                                                            \+                                           \+    AMC                      Continuation
  60   18 + 3         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
       20 + 3         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
  61   20 + 0         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
       22 + 0         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
  62   19 + 6         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
       21 + 6         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
  63   20 + 4         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
       22 + 4         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
  64   21 + 2         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
       23 + 2         ‐                        BPEV                              \+                                                            \+                                           \+    BPEV                     Continuation
  65   21 + 0         F/P/CT                   FADS                              ‐                                                             ‐                                            \+    FADS                     TOP
  66   11 + 5         ‐                        AMC                               ‐                                                             ‐                                            \+    FADS                     TOP

Abbreviations: (0), No movements seen; AMC, Arthrogryposis multiplex congenital; BPEV, bilateral pes equinovares; BPEV+K/H, bilateral pes equinovares and contractures knees/hips; Continuation, continuation of pregnancy; CT, increased cardio‐thorax ratio, longhypoplasia; F, flattening of the face; FADS, fetal akinesia deformation sequence; NA, not able to access; P, polyhydramnios; TOP, termination of pregnancy; U + L, contractures upper and lower limbs; W, contractures wrists; W + E/S, contractures wrists and elbows/shoulders. Motor assessment: +, Normal; ‐, Abnormal; +/‐, slightly abnormal; ‐ ‐, progressively abnormal; ++, increased.

Wrists and elbows are not participating in movements.

Reduced variability, mainly movements with large amplitude and fast movements, direction of movement does change, mainly participation of all body parts, not all fluently.

Hypo‐ and hyperkinetic movement patterns seen.

Included stepping, movements, so slightly reduced differentiation was interpreted as normal.
